Welcome to LookChem.com Sign In|Join Free

CAS

  • or

128740-14-7

Post Buying Request

128740-14-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128740-14-7 Usage

Description

6-Benzyl-Octahydro-Pyrrolo[3,4-b]Pyridine is an organic compound with a unique molecular structure that features a benzyl group attached to an octahydro-pyrrolo[3,4-b]pyridine ring. 6-BENZYL-OCTAHYDRO-PYRROLO[3,4-B]PYRIDINE is known for its potential applications in the pharmaceutical industry, particularly in the synthesis of various drugs.

Uses

Used in Pharmaceutical Industry:
6-Benzyl-Octahydro-Pyrrolo[3,4-b]Pyridine is used as an intermediate in the synthesis of Moxifloxacin (M745000), a fluorinated quinolone antibacterial. 6-BENZYL-OCTAHYDRO-PYRROLO[3,4-B]PYRIDINE plays a crucial role in the development of new antibiotics to combat bacterial infections, as Moxifloxacin is known for its broad-spectrum activity against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

Check Digit Verification of cas no

The CAS Registry Mumber 128740-14-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,7,4 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 128740-14:
(8*1)+(7*2)+(6*8)+(5*7)+(4*4)+(3*0)+(2*1)+(1*4)=127
127 % 10 = 7
So 128740-14-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2/c1-2-5-12(6-3-1)9-16-10-13-7-4-8-15-14(13)11-16/h1-3,5-6,13-15H,4,7-11H2

128740-14-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Benzyl-octahydropyrrolo[3,4-b]pyridine

1.2 Other means of identification

Product number -
Other names 6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128740-14-7 SDS

128740-14-7Relevant articles and documents

Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment

Wu, Songliang,Sun, Yu,Hu, Yi,Zhang, Hongmei,Hou, Lijuan,Liu, Xing,Li, Yufeng,He, Haiying,Luo, Zhi,Chen, Yuan,Wang, Yuhe,Shi, Weihua,Shen, Liang,Cao, Changqing,Liang, Wei,Xu, Qing,Lv, Qiang,Lan, Jiong,Li, Jian,Chen, Shuhui

, p. 1458 - 1462 (2017)

A series of octahydropyrrolo[3,4-c]pyrroles were synthesized and evaluated by orexin 1 and 2 receptor (OX1 & 2R) antagonists assays. Compound 14l with potent OXR antagonist activity and suitable pharmacokinetic behavior was chosen to be investigated in an EEG study, which demonstrated effects of sleep promotion comparable to Suvorexant. Furthermore, the di-fluro substituted analogs exhibited reduced hERG inhibition while maintaining moderate potency.

Catalytic Transfer Hydrodebenzylation with Low Palladium Loading

Yakukhnov, Sergey A.,Ananikov, Valentine P.

, p. 4781 - 4789 (2019/09/16)

A highly-efficient catalytic system for hydrodebenzylation reaction is described. The cleavage of O-benzyl and N-benzyl protecting groups was performed using an uncommonly low palladium loading (0.02–0.3 mol%; TON up to 5000) in a relatively short reaction time. The approach was used for a variety of substrates including pharmaceutically important precursors, and gram-scale deprotection reaction was shown. Transfer conditions together with easy-to-make Pd/C catalyst are the key features of this debenzylation scheme. (Figure presented.).

Efficient synthesis of (S,S)-2,8-diazabicyclo[4.3.0]nonane

Chen, Shipeng,Liu, Dongqi,Si, Leilei,Chen, Ligong,Yan, Xilong

supporting information, p. 238 - 244 (2017/01/22)

An efficient synthetic route for moxifloxacin chiral intermediate via five steps was established. First, dehydration, N-acylation, and cyclization were combined in one pot to meet the industrial requirement. Then relatively low hydrogen pressure was employed in the catalytic hydrogenation reaction with high yield. Isopropanol/water system was used in resolution, which guaranteed high yield and perfect optical purity. The racemic process conducted by manganese dioxide and Pd/C successfully converted the undesired enantiomer into the racemate and hence the total yield increased remarkably. Furthermore, mild hydrogen transfer catalytic hydrogenation method was utilized in debenzylation process instead of high-pressure hydrogenation. Total yield of 39.0% was achieved, which was much higher than that of 29.0% in literature.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128740-14-7